LIF.NASDAQLife360, INC

Form 4: Life360 Director James Synge Sells Shares in Multiple Transactions

Sentiment:

SEC Form 4 Filing


Life360 director James Synge sold a total of 25,000 common stock equivalent shares through multiple transactions on November 26, 2024, at weighted average prices of $43.81 and $44.63.

Summary

  • James Synge, a director at Life360, sold 10,723 common stock equivalent shares at a weighted average price of $43.81 on November 26, 2024.
  • He also sold 14,277 common stock equivalent shares at a weighted average price of $44.63 on the same day.
  • These sales were executed through the conversion of Chess Depositary Interests (CDIs) traded on the Australian Securities Exchange (ASX).
  • The CDIs were converted to common stock at a 1:3 ratio.
  • The prices reported are weighted averages, with individual transactions occurring within ranges of $43.34 to $44.33 and $44.37 to $44.90 respectively.
  • Synge also indirectly holds 3,966 shares through ICCA Labs, LLC, which was previously omitted in a September 9, 2024 filing.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of share sales by a director. It doesn't inherently indicate positive or negative sentiment, but the market may react to the director's selling activity.

Risks

  • The sale of shares by a director could be perceived negatively by the market, potentially impacting the stock price.

Industry Context

This is a standard SEC Form 4 filing, which is common for company directors and officers who trade shares in their own company. Such filings are a regular part of the market and are closely watched by investors for insights into management's view of the company's prospects.

Comparison to Industry Standards

  • Form 4 filings are a standard practice for publicly traded companies in the US, and the information provided is consistent with what is typically disclosed in such filings.
  • The sale of shares by a director is not unusual, but the market reaction can vary depending on the size of the sale and the overall market sentiment.
  • Comparable companies would also have similar filings when directors or officers trade shares.

Stakeholder Impact

  • Shareholders may react to the director's share sales, potentially impacting the stock price.

Key Dates

DateDescription
09/09/2024Date of a previous Form 4 filing that inadvertently omitted indirectly held shares.
11/26/2024Date of the reported share sales by James Synge.
11/27/2024Date of the signature on the Form 4 filing.

Keywords

Life360, James Synge, share sale, director, insider trading, Chess Depositary Interests, ASX, ICCA Labs, common stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.